LGM
Logos Global Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Hold |
275,000
| – | – | 0.49% | 37 |
|
|
2025
Q1 | $4.7M | Sell |
275,000
-25,000
| -8% | -$427K | 0.84% | 27 |
|
|
2024
Q4 | $7.43M | Sell |
300,000
-800,000
| -73% | -$19.8M | 0.87% | 33 |
|
|
2024
Q3 | $31.4M | Buy |
1,100,000
+525,000
| +91% | +$15M | 3.38% | 8 |
|
|
2024
Q2 | $15.2M | Sell |
575,000
-1,200,000
| -68% | -$31.7M | 1.22% | 19 |
|
|
2024
Q1 | $57.4M | Buy |
1,775,000
+575,000
| +48% | +$18.6M | 4.64% | 3 |
|
|
2023
Q4 | $50.6M | Sell |
1,200,000
-400,000
| -25% | -$16.9M | 4.72% | 6 |
|
|
2023
Q3 | $61.4M | Sell |
1,600,000
-650,000
| -29% | -$25M | 8.19% | 1 |
|
|
2023
Q2 | $42.7M | Sell |
2,250,000
-250,000
| -10% | -$4.74M | 5.81% | 3 |
|
|
2023
Q1 | $38.8M | Sell |
2,500,000
-650,000
| -21% | -$10.1M | 5.55% | 4 |
|
|
2022
Q4 | $55.9M | Buy |
+3,150,000
| New | +$55.9M | 6.55% | 4 |
|
|
2020
Q3 | – | Sell |
-625,000
| Closed | -$15.2M | – | 54 |
|
|
2020
Q2 | $15.2M | Buy |
+625,000
| New | +$15.2M | 3.04% | 13 |
|